JP2007502101A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502101A5 JP2007502101A5 JP2006521226A JP2006521226A JP2007502101A5 JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5 JP 2006521226 A JP2006521226 A JP 2006521226A JP 2006521226 A JP2006521226 A JP 2006521226A JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- acid sequence
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48984003P | 2003-07-24 | 2003-07-24 | |
| US52011503P | 2003-11-14 | 2003-11-14 | |
| PCT/US2004/023523 WO2005009379A2 (en) | 2003-07-24 | 2004-07-22 | Polypeptides for inducing a protective immune response against staphylococcus aureus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502101A JP2007502101A (ja) | 2007-02-08 |
| JP2007502101A5 true JP2007502101A5 (enExample) | 2007-05-24 |
Family
ID=34107815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521226A Pending JP2007502101A (ja) | 2003-07-24 | 2004-07-22 | スタフィロコッカス・アウレウスに対して防御免疫応答を誘導するポリペプチド |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20060177462A1 (enExample) |
| EP (1) | EP1651166B8 (enExample) |
| JP (1) | JP2007502101A (enExample) |
| KR (1) | KR20060065643A (enExample) |
| AT (1) | ATE457737T1 (enExample) |
| AU (1) | AU2004258979B2 (enExample) |
| BR (1) | BRPI0412799A (enExample) |
| CA (1) | CA2532370A1 (enExample) |
| CY (1) | CY1110028T1 (enExample) |
| DE (1) | DE602004025579D1 (enExample) |
| DK (1) | DK1651166T3 (enExample) |
| ES (1) | ES2342778T3 (enExample) |
| HR (1) | HRP20100240T1 (enExample) |
| IL (1) | IL173253A0 (enExample) |
| IS (1) | IS8213A (enExample) |
| MX (1) | MXPA06000854A (enExample) |
| NO (1) | NO20060898L (enExample) |
| NZ (2) | NZ544542A (enExample) |
| PL (1) | PL1651166T3 (enExample) |
| PT (1) | PT1651166E (enExample) |
| RU (1) | RU2337108C2 (enExample) |
| SI (1) | SI1651166T1 (enExample) |
| WO (1) | WO2005009379A2 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| WO2005079315A2 (en) * | 2004-02-18 | 2005-09-01 | Merck & Co., Inc. | Polypeptides for inducing a protective immune response against staphylococcus aureus |
| KR20070085457A (ko) * | 2004-10-25 | 2007-08-27 | 더 유니버시티 오브 웨스턴 온타리오 | 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법 |
| GB0526038D0 (en) * | 2005-12-21 | 2006-02-01 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| AU2007210170A1 (en) * | 2006-01-27 | 2007-08-09 | Merck Sharp & Dohme Corp. | Antigen-binding proteins targeting S. aureus ORF0657n |
| JP2010516279A (ja) | 2007-01-24 | 2010-05-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 表皮ブドウ球菌に対する防御免疫応答を誘導するためのポリペプチド |
| EP1987836B1 (en) * | 2007-05-04 | 2011-12-21 | Martin Krönke | Protective staphylococcus aureus vaccine based on cell wall-associated proteins |
| EP2164869A2 (en) * | 2007-05-31 | 2010-03-24 | Merck Sharp & Dohme Corp. | Antigen-binding proteins targeting s. aureus orf0657n |
| WO2009022236A2 (en) | 2007-08-16 | 2009-02-19 | Tripep Ab | Immunogen platform |
| US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| JP5658564B2 (ja) | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
| US8758765B2 (en) | 2008-07-29 | 2014-06-24 | The University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
| EP2376111A4 (en) | 2008-11-26 | 2013-01-09 | Merck Sharp & Dohme | POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS |
| EP3281947B1 (en) | 2009-04-03 | 2020-02-12 | The University of Chicago | Compositions and methods related to protein a (spa) variants |
| NZ612315A (en) | 2009-04-14 | 2014-10-31 | Novartis Ag | Compositions for immunising against staphylococcus aureus |
| GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| EP2493510B1 (en) | 2009-09-30 | 2020-07-08 | GlaxoSmithKline Biologicals SA | Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides |
| PL2493498T3 (pl) | 2009-10-30 | 2017-08-31 | Glaxosmithkline Biologicals Sa | Oczyszczanie sacharydów otoczkowych staphylococcus aureus typu 5 i typu 8 |
| GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
| EP2544709A4 (en) * | 2010-03-12 | 2014-01-08 | Univ Pennsylvania | METHOD FOR PREVENTING AND TREATING THE COLONIZATION OF STAPHYLOCOCCUS AUREUS AND THEIR INFECTIOUS DISEASES AND DISEASES |
| ES2655701T3 (es) | 2010-07-02 | 2018-02-21 | The University Of Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SpA) |
| WO2012021229A1 (en) | 2010-07-13 | 2012-02-16 | Merck Sharp & Dohme Corp. | Staphylococcus aureus surface protein sa1789 and protective vaccine based thereon |
| EP2638058B1 (en) | 2010-11-12 | 2017-01-11 | Merck Sharp & Dohme Corp. | Enolase peptide conjugate vaccines against staphylococcus aureus |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| BR112014004782A2 (pt) | 2011-09-01 | 2017-03-21 | Novartis Ag | formulações adjuvantes de antígenos de staphylococcus aureus |
| US9527892B2 (en) | 2011-10-31 | 2016-12-27 | Merck Sharp & Dohme Corp. | Protective vaccine based on Staphylococcus aureus SA2451 protein |
| MX2014014804A (es) | 2012-06-27 | 2015-02-12 | Hoffmann La Roche | Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo. |
| EP2867253B1 (en) | 2012-06-27 | 2016-09-14 | F. Hoffmann-La Roche AG | Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof |
| EP2872173A4 (en) | 2012-07-10 | 2016-03-23 | Merck Sharp & Dohme | PROTECTIVE VACCINE BASED ON THE STAPHYLOCOCCUS AUREUS PROTEIN SA2493 |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| AU2020273471B2 (en) | 2019-05-14 | 2026-05-07 | The University Of Chicago | Methods and compositions comprising Staphylococcus protein A (SpA) variants |
| US12528882B2 (en) | 2019-09-13 | 2026-01-20 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| CA2373221A1 (en) * | 1999-05-03 | 2000-11-30 | Yashwant M. Deo | Human antibodies to staphylococcus aureus |
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| WO2002102829A2 (en) * | 2001-06-15 | 2002-12-27 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| ES2322338T3 (es) * | 2001-11-12 | 2009-06-19 | Novo Nordisk A/S | Purificacion de peptidos por medio de cromatografia de afinidad con iones metalicos. |
| JP2005532415A (ja) * | 2001-12-11 | 2005-10-27 | メルク エンド カムパニー インコーポレーテッド | スタフィロコッカス・アウレウスエキソポリサッカライド及び方法 |
| US20080050361A1 (en) * | 2004-10-25 | 2008-02-28 | Heinrichs David E | Staphylococcus aureas specific anti-infectives |
| EP1998800A2 (en) * | 2006-01-18 | 2008-12-10 | University Of Chicago | Compositions and methods related to staphylococcal bacterium proteins |
-
2004
- 2004-07-22 MX MXPA06000854A patent/MXPA06000854A/es active IP Right Grant
- 2004-07-22 SI SI200431389T patent/SI1651166T1/sl unknown
- 2004-07-22 NZ NZ544542A patent/NZ544542A/en not_active IP Right Cessation
- 2004-07-22 PT PT04778847T patent/PT1651166E/pt unknown
- 2004-07-22 RU RU2006105498/13A patent/RU2337108C2/ru not_active IP Right Cessation
- 2004-07-22 BR BRPI0412799-4A patent/BRPI0412799A/pt not_active Application Discontinuation
- 2004-07-22 PL PL04778847T patent/PL1651166T3/pl unknown
- 2004-07-22 AT AT04778847T patent/ATE457737T1/de active
- 2004-07-22 ES ES04778847T patent/ES2342778T3/es not_active Expired - Lifetime
- 2004-07-22 WO PCT/US2004/023523 patent/WO2005009379A2/en not_active Ceased
- 2004-07-22 AU AU2004258979A patent/AU2004258979B2/en not_active Ceased
- 2004-07-22 DE DE602004025579T patent/DE602004025579D1/de not_active Expired - Lifetime
- 2004-07-22 CA CA002532370A patent/CA2532370A1/en not_active Abandoned
- 2004-07-22 US US10/564,458 patent/US20060177462A1/en not_active Abandoned
- 2004-07-22 HR HR20100240T patent/HRP20100240T1/hr unknown
- 2004-07-22 KR KR1020067001610A patent/KR20060065643A/ko not_active Ceased
- 2004-07-22 DK DK04778847.6T patent/DK1651166T3/da active
- 2004-07-22 JP JP2006521226A patent/JP2007502101A/ja active Pending
- 2004-07-22 NZ NZ570750A patent/NZ570750A/en not_active IP Right Cessation
- 2004-07-22 EP EP04778847A patent/EP1651166B8/en not_active Expired - Lifetime
-
2005
- 2005-12-30 IS IS8213A patent/IS8213A/is unknown
-
2006
- 2006-01-19 IL IL173253A patent/IL173253A0/en unknown
- 2006-02-23 NO NO20060898A patent/NO20060898L/no not_active Application Discontinuation
-
2010
- 2010-04-30 US US12/771,345 patent/US20100247561A1/en not_active Abandoned
- 2010-05-14 CY CY20101100419T patent/CY1110028T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2006105498A (ru) | Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus | |
| CN114634556B (zh) | 一种新冠病毒Delta和Omicron变异株嵌合抗原、其制备方法和应用 | |
| JP2008529558A5 (enExample) | ||
| JP2002537791A5 (enExample) | ||
| JP2002510494A5 (enExample) | ||
| JP2006516189A5 (enExample) | ||
| JPH09322781A5 (enExample) | ||
| JP2002542827A5 (enExample) | ||
| JP2008538183A5 (enExample) | ||
| JP2002531129A5 (enExample) | ||
| JP2008525033A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| CN116041448B (zh) | 新型冠状病毒免疫原性物质、其制备方法和应用 | |
| CA2385325A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| CN117050193B (zh) | 一种β冠状病毒重组嵌合抗原、其制备方法及应用 | |
| WO1993020844A1 (en) | Papillomavirus e7 protein | |
| WO2024067725A1 (zh) | 一种融合前构象的呼吸道合胞病毒重组融合蛋白、其制备方法及用途 | |
| JP2002511847A (ja) | Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓに関連した歯周病の診断および治療のための合成ペプチド構築物 | |
| JP2004502446A5 (enExample) | ||
| JPH0775546B2 (ja) | 水痘−帯状疱疹ウイルスにたいするワクチン | |
| JP2025512062A5 (enExample) | ||
| JP2004532037A5 (enExample) | ||
| CN102633867A (zh) | 抗原性改变的肠毒素c2突变体及编码基因与制备和应用 | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| US20230220012A1 (en) | High-potency sars coronavirus 2 antigen and vaccine composition comprising same |